Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

No treatment fully prevents hair loss from chemotherapy yet.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Hair follicle melanocytes die during hair regression.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Researchers developed a new, precise method to measure hair loss in mice using image analysis.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Vitamin C was found to effectively treat prickly heat in children.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Bee venom helps hair grow and may work better than some common treatments.